In summary, the PNPLA3 I148M variant as a risk factor for MASLD is sex-dependent, and PNPLA3 I148M could influence the progression of MASLD and cardiovascular outcomes in female subjects. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.